Gate2Brain

Description

Gate2Brain produces a peptide-based, patented technology platform of three peptide-shuttle families that improve delivery and biopharmaceutical properties of conjugated cargoes, enabling therapeutics to cross biological barriers such as the blood–brain barrier.

Gate2Brain is located in the Barcelona ecosystem.

Related

• CARTHERACARTHERA develops SonoCloud, an implanted ultrasound device that emits low-intensity pulsed ultrasound to transiently open the blood–brain…
• BioArcticBioArctic develops therapeutics and related technologies for neurodegenerative disorders, focusing on disease-modifying treatments and…
• IonKraftIonKraft develops IONX, a glass-like nano barrier coating for plastic packaging, using plasma-based barrier layer deposition and automated…
• Arthex BiotechArthex Biotech develops RNA-based therapeutics, including an anti‑miR program delivered via fatty‑acid conjugated oligonucleotides to…
• inbrain-neuroelectronicsinbrain-neuroelectronics develops a graphene-based brain–computer interface that detects high-frequency neural activity with…
• NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
• SpliceBioSpliceBio builds protein splicing–based genetic medicines and develops therapeutics for diseases caused by mutations in large genes,…
• AortyxAortyx develops a bioresorbable biomimetic endovascular patch and a dual-steerable catheter delivery system to seal aortic dissection entry…
• ceregateceregate provides a hardware-agnostic computer–brain interface platform that enables new communication channels with the brain to restore…